Group 1 - The core point of the news is that southbound funds have significantly increased their holdings in Jinxin Reproductive Medicine (01951.HK), with a total net increase of 29.76 million shares over the past five trading days [1] - As of September 18, 2025, southbound funds hold a total of 1.408 billion shares of Jinxin Reproductive Medicine, accounting for 51.05% of the company's total issued ordinary shares [1][2] - In the last 20 trading days, there have been 16 days of net increases in holdings by southbound funds, totaling 114 million shares [1] Group 2 - The company, Jinxin Reproductive Medicine, is an investment holding company primarily providing in vitro fertilization (IVF) services [2] - The company offers a range of services through its subsidiaries, including assisted reproductive services, management services, mobile surgical center facilities, auxiliary medical services, and sales of medical consumables and equipment [2] - Jinxin Reproductive Medicine operates mainly in China and the United States [2]
锦欣生殖（01951.HK）：9月18日南向资金增持691.35万股